Latest developments in SPC's: Patent term extensions
Changes in supplementary protection certificates can mean a difference of millions of euros per month for the value of pharmaceutical products, say Dr Martin Huenges and Dr Dirk Bühler of Maiwald
Patents are frequently a decisive factor in determining whether a new pharmaceutical product will be a success story. There are many reasons why this is. In contrast with other industries, a new pharmaceutical product, such as a new therapeutically active...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.